Diagnostic potential of extracellular vesicle‑associated microRNA‑10b and tumor markers for lung adenocarcinoma

Yuan,Guangda; Xie,Hongya; Wei,Tengteng; Zhu,Donglin; Zhang,Chuanyu; Yang,Yong

doi:10.3892/ol.2021.12875

Diagnostic potential of extracellular vesicle‑associated microRNA‑10b and tumor markers for lung adenocarcinoma

Authors:
- Guangda Yuan
- Hongya Xie
- Tengteng Wei
- Donglin Zhu
- Chuanyu Zhang
- Yong Yang
View Affiliations

Affiliations: Department of Thoracic Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu 215000, P.R. China
Published online on: June 23, 2021 https://doi.org/10.3892/ol.2021.12875
Article Number: 614
Copyright: © Yuan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miRNAs/miRs) in extracellular vesicles (EVs) are potential diagnostic markers. The purpose of the present study was to investigate potential EV miRNA biomarkers for lung adenocarcinoma (LUAD). Potential miRNAs were identified by searching public databases and verified by examining clinical samples. The diagnostic value of EV‑associated miR‑10b, plasma miR‑10b and tumor markers (TMs), including α‑fetoprotein (AFP), neuron‑specific enolase, carcinoembryonic antigen (CEA), cytokeratin 19 fragment 21‑1 (CYFRA211), pro‑gastrin‑releasing‑peptide, carbohydrate antigen (CA)125, CA153, CA199 and CA724, was evaluated via receiver operating characteristic curve analysis. By searching the Gene Expression Omnibus and The Cancer Genome Atlas databases, miR‑10b was identified as a potential biomarker. The analysis of clinical samples suggested that EV‑associated miR‑10b from plasma was significantly differentially expressed between LUAD and control samples. EV‑associated miR‑10b could function as a diagnostic marker for LUAD, with an AUC of 0.998, which was higher than the AUCs for TMs such as AFP, CEA, CYFRA211, CA125, CA153, CA199, CA724, pro‑gastrin‑releasing‑peptide and neuron‑specific enolase. In conclusion, EV‑associated miR‑10b may be a potential diagnostic biomarker for LUAD that is superior to plasma miR‑10b and TMs.

View Figures

View References

1	Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
2	Yan Y, Chen Y, Jia H, Liu J, Ding Y, Wang H, Hu Y, Ma J, Zhang X and Li S: Patterns of Life Lost to Cancers with High Risk of Death in China. Int J Environ Res Public Health. 16:2175–2193. 2019. View Article : Google Scholar : PubMed/NCBI
3	Zheng RS, Sun KX, Zhang SW, Zeng HM, Zou XN, Chen R, Gu XY, Wei WW and He J: Report of cancer epidemiology in China, 2015. Zhonghua Zhong Liu Za Zhi. 41:19–28. 2019.(In Chinese). PubMed/NCBI
4	Zhang H, Guo L and Chen J: Rationale for Lung Adenocarcinoma Prevention and Drug Development Based on Molecular Biology During Carcinogenesis. OncoTargets Ther. 13:3085–3091. 2020. View Article : Google Scholar : PubMed/NCBI
5	Zhang X, Wu L, Xu Y, Zhang B, Wu X, Wang Y and Pang Z: Trends in the incidence rate of lung cancer by histological type and gender in Sichuan, China, 1995–2015: A single-center retrospective study. Thorac Cancer. 9:532–541. 2018. View Article : Google Scholar : PubMed/NCBI
6	Dama E, Melocchi V, Mazzarelli F, Colangelo T, Cuttano R, Di Candia L, Ferretti GM, Taurchini M, Graziano P and Bianchi F: Non-Coding RNAs as Prognostic Biomarkers: A miRNA Signature Specific for Aggressive Early-Stage Lung Adenocarcinomas. Noncoding RNA. 6:482020.PubMed/NCBI
7	Yang W, Qian F, Teng J, Wang H, Manegold C, Pilz LR, Voigt W, Zhang Y, Ye J, Chen Q, et al Written on behalf of the AME Thoracic Surgery Collaborative Group, : Community-based lung cancer screening with low-dose CT in China: Results of the baseline screening. Lung Cancer. 117:20–26. 2018. View Article : Google Scholar : PubMed/NCBI
8	Liang F, Wu C, Gu H, Zhu M, Xuan Z, Jiang Y, Chen H, Fu C and Zheng Y: Lung cancer incidence in female rises significantly in urban sprawl of Shanghai after introduction of LDCT screening. Lung Cancer. 132:114–118. 2019. View Article : Google Scholar : PubMed/NCBI
9	He D, Yu H and Chen Y: Equity in the distribution of CT and MRI in China: A panel analysis. Int J Equity Health. 12:39–53. 2013. View Article : Google Scholar : PubMed/NCBI
10	Siravegna G, Mussolin B, Venesio T, Marsoni S, Seoane J, Dive C, Papadopoulos N, Kopetz S, Corcoran RB, Siu LL, et al: How liquid biopsies can change clinical practice in oncology. Ann Oncol. 30:1580–1590. 2019. View Article : Google Scholar : PubMed/NCBI
11	Sell S: Cancer markers of the 1990s. Comparison of the new generation of markers defined by monoclonal antibodies and oncogene probes to prototypic markers. Clin Lab Med. 10:1–37. 1990. View Article : Google Scholar : PubMed/NCBI
12	He Y, Lu H and Zhang L: Serum AFP levels in patients suffering from 47 different types of cancers and noncancer diseases. Prog Mol Biol Transl Sci. 162:199–212. 2019. View Article : Google Scholar : PubMed/NCBI
13	Beauchemin N and Arabzadeh A: Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis. Cancer Metastasis Rev. 32:643–671. 2013. View Article : Google Scholar : PubMed/NCBI
14	Grunnet M and Sorensen JB: Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer. 76:138–143. 2012. View Article : Google Scholar : PubMed/NCBI
15	Lei L, Chen Q, Wang Z, Han N, Chen B, Qin J and Lu HY: Usefulness of carcinoembryonic antigen in the diagnosis of small cell lung cancer combined with adenocarcinoma. Adv Clin Exp Med. 26:1091–1094. 2017. View Article : Google Scholar : PubMed/NCBI
16	Nakamura H and Nishimura T: History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer. Surg Today. 47:1037–1059. 2017. View Article : Google Scholar : PubMed/NCBI
17	Li X, Xu Y and Zhang L: Serum CA153 as biomarker for cancer and noncancer diseases. Prog Mol Biol Transl Sci. 162:265–276. 2019. View Article : Google Scholar : PubMed/NCBI
18	Buccheri G and Ferrigno D: Lung tumor markers of cytokeratin origin: An overview. Lung Cancer. 34 (Suppl 2):S65–S69. 2001. View Article : Google Scholar : PubMed/NCBI
19	Uenishi T, Kubo S, Hirohashi K, Tanaka H, Shuto T, Yamamoto T and Nishiguchi S: Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer. Br J Cancer. 88:1894–1899. 2003. View Article : Google Scholar : PubMed/NCBI
20	Narita T, Funahashi H, Imai T, Takagi H and Kannagi R: Cytosol and serum concentration of cytokeratin subunit-19 fragment (cyfra-21-1) in breast-cancer. Oncol Rep. 1:747–750. 1994.PubMed/NCBI
21	Kammer MN, Kussrow AK, Webster RL, Chen H, Hoeksema M, Christenson R, Massion PP and Bornhop DJ: Compensated Interferometry Measures of CYFRA 21-1 Improve Diagnosis of Lung Cancer. ACS Comb Sci. 21:465–472. 2019. View Article : Google Scholar : PubMed/NCBI
22	Yang G, Xiao Z, Tang C, Deng Y, Huang H and He Z: Recent advances in biosensor for detection of lung cancer biomarkers. Biosens Bioelectron. 141:1114162019. View Article : Google Scholar : PubMed/NCBI
23	Gu Y, Liu S, Zhang X, Chen G, Liang H, Yu M, Liao Z, Zhou Y, Zhang CY, Wang T, et al: Oncogenic miR-19a and miR-19b co-regulate tumor suppressor MTUS1 to promote cell proliferation and migration in lung cancer. Protein Cell. 8:455–466. 2017. View Article : Google Scholar : PubMed/NCBI
24	Yuan L, Bing Z, Yan P, Li R, Wang C, Sun X, Yang J, Shi X, Zhang Y and Yang K: Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity. Gene. 716:144025. 2019. View Article : Google Scholar : PubMed/NCBI
25	Dai B, Kong D-L, Tian J, Liu T-W, Zhou H and Wang ZF: microRNA-1205 promotes cell growth by targeting APC2 in lung adenocarcinoma. Eur Rev Med Pharmacol Sci. 23:1125–1133. 2019.PubMed/NCBI
26	Wang SS, Fang YY, Huang JC, Liang YY, Guo YN, Pan LJ and Chen G: Clinical value of microRNA-198-5p downregulation in lung adenocarcinoma and its potential pathways. Oncol Lett. 18:2939–2954. 2019.PubMed/NCBI
27	Sheu-Gruttadauria J, Pawlica P, Klum SM, Wang S, Yario TA, Schirle Oakdale NT, Steitz JA and MacRae IJ: Structural Basis for Target-Directed MicroRNA Degradation. Mol Cell. 75:1243–1255.e7. 2019. View Article : Google Scholar : PubMed/NCBI
28	Barile L and Vassalli G: Exosomes: Therapy delivery tools and biomarkers of diseases. Pharmacol Ther. 174:63–78. 2017. View Article : Google Scholar : PubMed/NCBI
29	Kowal EJK, Ter-Ovanesyan D, Regev A and Church GM: Extracellular Vesicle Isolation and Analysis by Western Blotting. Methods Mol Biol. 1660:143–152. 2017. View Article : Google Scholar : PubMed/NCBI
30	Shan B, Ai Z, Zeng S, Song Y, Song J, Zeng Q, Liao Z, Wang T, Huang C and Su D: Gut microbiome-derived lactate promotes to anxiety-like behaviors through GPR81 receptor-mediated lipid metabolism pathway. Psychoneuroendocrinology. 117:1046992020. View Article : Google Scholar : PubMed/NCBI
31	Su D, Liao Z, Feng B, Wang T, Shan B, Zeng Q, Song J and Song Y: Pulsatilla chinensis saponins cause liver injury through interfering ceramide/sphingomyelin balance that promotes lipid metabolism dysregulation and apoptosis. Phytomedicine. 76:1532652020. View Article : Google Scholar : PubMed/NCBI
32	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
33	Nagy Á, Lánczky A, Menyhárt O and Győrffy B: Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep. 8:9227–9235. 2018. View Article : Google Scholar : PubMed/NCBI
34	Nigita G, Distefano R, Veneziano D, Romano G, Rahman M, Wang K, Pass H, Croce CM, Acunzo M and Nana-Sinkam P: Tissue and exosomal miRNA editing in Non-Small Cell Lung Cancer. Sci Rep. 8:10222–10229. 2018. View Article : Google Scholar : PubMed/NCBI
35	Karagkouni D, Paraskevopoulou MD, Chatzopoulos S, Vlachos IS, Tastsoglou S, Kanellos I, Papadimitriou D, Kavakiotis I, Maniou S, Skoufos G, et al: DIANA-TarBase v8: A decade-long collection of experimentally supported miRNA-gene interactions. Nucleic Acids Res. 46D:D239–D245. 2018. View Article : Google Scholar : PubMed/NCBI
36	Agarwal V, Bell GW, Nam JW and Bartel DP: Predicting effective microRNA target sites in mammalian mRNAs. eLife. 4:e05005–e05042. 2015. View Article : Google Scholar : PubMed/NCBI
37	Paraskevopoulou MD, Georgakilas G, Kostoulas N, Vlachos IS, Vergoulis T, Reczko M, Filippidis C, Dalamagas T and Hatzigeorgiou AG: DIANA-microT web server v5.0: Service integration into miRNA functional analysis workflows. Nucleic Acids Res. 41W:W169–W173. 2013. View Article : Google Scholar : PubMed/NCBI
38	Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and Varambally S: UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 19:649–658. 2017. View Article : Google Scholar : PubMed/NCBI
39	Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT, et al: The GeneMANIA prediction server: Biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 38 (Suppl 2):W214–W220. 2010. View Article : Google Scholar : PubMed/NCBI
40	Hong QY, Wu GM, Qian GS, Hu CP, Zhou JY, Chen LA, Li WM, Li SY, Wang K, Wang Q, et al Lung Cancer Group of Chinese Thoracic Society; Chinese Alliance Against Lung Cancer, : Prevention and management of lung cancer in China. Cancer. 121 (Suppl 17):3080–3088. 2015. View Article : Google Scholar : PubMed/NCBI
41	Jiang ZF, Wang M and Xu JL: Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer. Life Sci. 194:1–6. 2018. View Article : Google Scholar : PubMed/NCBI
42	Isgrò MA, Bottoni P and Scatena R: Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects. Adv Exp Med Biol. 867:125–143. 2015. View Article : Google Scholar
43	Papagiannakopoulos T, Bauer MR, Davidson SM, Heimann M, Subbaraj L, Bhutkar A, Bartlebaugh J, Vander Heiden MG and Jacks T: Circadian Rhythm Disruption Promotes Lung Tumorigenesis. Cell Metab. 24:324–331. 2016. View Article : Google Scholar : PubMed/NCBI
44	Schier AC and Taatjes DJ: Structure and mechanism of the RNA polymerase II transcription machinery. Genes Dev. 34:465–488. 2020. View Article : Google Scholar : PubMed/NCBI
45	Huang J, Sun C, Wang S, He Q and Li D: MicroRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells. Mol Biosyst. 11:2051–2059. 2015. View Article : Google Scholar : PubMed/NCBI